Select Committee on Science and Technology Minutes of Evidence


Examination of Witnesses (Questions 560-579)

DR JEAN MONRO, DR DAMIEN DOWNING, MR DON HARRISON AND PROFESSOR SIMON WESSELY

21 FEBRUARY 2007

  Q560  Baroness Platt of Writtle: If a patient seeks medical advice about a possible allergy what are the differences in approach between an environmental allergist and an NHS allergy specialist?

  Dr Downing: So I am an environmental allergist then! Fair enough. Somebody who comes to see a member of our society with these things would be approached on a much broader basis and we would be looking at not simply the narrow definition of allergy that has been used, which is kind of falling apart these days, but is still there, which is that allergies cause IgE-mediated diseases such as asthma, eczema and so forth. We see a lot of people with a huge range of other diseases that have been shown in individual instances to have allergic or hypersensitivity mechanisms involved in them, and the link between food intolerance and arthritis would be an obvious example of that. So somebody coming to one of our clinics would be assessed in those terms and would also have their nutritional status looked at, and they would have their toxicological status considered as well, and of course we would also rope in lifestyle and psychological factors.

  Q561  Baroness Perry of Southwark: I would like you to explain to us something about what I think is called the provocation or neutralisation test which is used by environmental allergists; how does it work?

  Dr Monro: It is a form of low-dose immunotherapy. In your previous questioning you were asking the panel on homeopathy and they said that the doses used were very infinitesimal whereas in neutralisation techniques the doses are tested for an individual according to the individual's responses and it is a form of low-dose immunotherapy. It has been used as a sublingual form of immunotherapy and there are now some 3,000-odd papers on sublingual immunotherapy and how effective it can be. I think Dr Brostoff said that it was a technique that was approved by the European Academy of Allergy and accepted by them. Furthermore, low-dose immunotherapy has been shown to be the most effective disease-modifying form of treatment as opposed to disease-suppressing form of treatment for people with allergies.

  Q562  Baroness Perry of Southwark: As I understand it, the provocation test comes first and then is followed by the neutralisation vaccines. Am I right? Perhaps you could tell me what quality controls there are for those vaccines that are used?

  Dr Monro: What is used is a series of different strengths of vaccines starting with one particular strength and it is titrated as a low dose from there in strengths of perhaps one part in five, so the strengths of the initial vaccine are well known and they have been established. The dilutions are parts of that, perhaps one in 25 or one in 125 parts, just as an example, so that when one knows the original strength one can calculate what the strengths of the others are. The point about it is that immunotherapy has been shown to be beneficial. I can quote from a paper from Nature Reviews Immunology in October last year which says: "It will prevent the onset of new sensitisations to different allergens, reduce the development of asthma in patients with allergic rhinitis caused by inhaled allergens, and it is disease modifying rather than palliative.

  Q563  Baroness Perry of Southwark: Where did you say that article appeared?

  Dr Monro: That is from Nature Reviews Immunology, volume six, October 2006.

  Q564  Baroness Perry of Southwark: I was going to ask about a double blind study of the provocation tests, which I am still not quite clear about. You have talked a lot about the immunisation programme but I am not quite clear what the provocation test is. I wanted to press you really on the study that was published in the New England Journal of Medicine in 1990 where they said that the provocation test had no value in identifying food sensitivities. Has there been any study afterwards specifically on the diagnostic test?

  Dr Monro: Yes, there have been and I have a dossier of information about it. That paper was by Jewett and it was critiqued by a number of people who actually practised provocation neutralisation. He did not actually practise it, he is an orthopaedic person, but the point is that the critique has shown that the techniques that he was recommending were not entirely valid.

  Q565  Baroness Perry of Southwark: So the provocation test is what, giving somebody a dose?

  Dr Monro: It is giving a dose of allergen which is at a particular strength that I have mentioned and then that can provoke symptoms in a person which can be nullified by a weaker strength.

  Q566  Baroness Perry of Southwark: So how many provocation tests would you have to have before you could identify what it was that the patient was allergic to?

  Dr Monro: Whatever the strength of solutions it is that is being used, say wheat diluted to a fifth of a standard concentration, that can be used as provocation. The next weaker dose could be used as a treatment, so it is a series of different strengths.

  Q567  Baroness Perry of Southwark: How do you find out which allergen the patient is reacting to? Would they have to have 20 or 30 different allergens given to them as provocation?

  Dr Monro: They may have to but quite often if one has a history of a problem in an individual—and that is where the skill of the environmental physician is used—you identify the things that you suspect might be a problem and that is the item that is tested, and you might have three or four items in an individual or you might have ten.

  Q568  Baroness Perry of Southwark: Since that New England Journal article in 1990, have there been any research reports showing that the 1990 report was wrong, that these provocation tests do work, and can you give us a quote?

  Dr Monro: Yes I can, I have got a dossier of them but, in addition, as I say, since then there has also been a vast literature on sublingual immunotherapy, which is part of the provocation testing technique, which shows that low-dose immunotherapy is very effective, and I am happy to provide the Committee with the relevant documents.

  Mr Harrison: I agree with the validity of the provocation test certainly but we use a different type of testing. We use the type of testing beloved of Professor Corrigan. We use muscle testing, we use kinesiology. The test is comparatively short and it can be anywhere between 20 and a couple of hundred allergens. The case history taking has to be long. The remedies that are used and that are produced in our own pharmacy are dilutions of one in 100. In other words, they are homeopathic centesimal dilutions going up to the 30th centesimal potency; sometimes to the 200th and sometimes higher, but usually the 30th is adequate, and so we are way beyond the level of actual material in our remedies; we are looking at energy medicines rather than anything else. The test is short and more time is probably devoted to the case history.

  Q569  Chairman: Again I am going to shorten you because Professor Wessely has been patiently waiting to make a comment.

  Professor Wessely: The Jewett test in the New England Journal was one of a large number of double blind provocation studies and what these show is that where the blindness is maintained thoroughly, in other words neither the patient nor the doctor is able to guess or work out what the provocation is, they give consistently negative results, no better than chance alone. Where either the doctor or the patient is unblinded, they give positive tests. It is for that reason that the provocation tests are not used to diagnose sensitivities.

  Q570  Baroness Perry of Southwark: I am grateful for that. Could I just return to the difference between the neutralisation process that Dr Monro is talking about and conventional sublingual therapy which we have certainly seen practised for example in Germany and elsewhere. What is the difference between the two?

  Dr Monro: The difference is simply that one uses in a neutralising technique a series of different solutions and one uses the solution which produces no adverse effects as a treatment, the strength can then be increased. It is perfectly safe to do sublingually because there are known to be very few what are called mast cells in the mouth and under the tongue so that a person can be given a treatment very safely without the likelihood of adverse effects. So the neutralisation technique is to find a strength which gives no symptoms and then you can increase the dose thereafter sublingually in a form of low-dose immunotherapy.

  Q571  Baroness Perry of Southwark:So it is different from the sublingual therapy which is used in conventional allergy treatment?

  Dr Monro: It is not entirely different. As I say, one can use one of the strengths and then build it up so that in fact it becomes the same thing.

  Q572  Chairman: Could I just clarify, would that technique apply to something like peanut allergy?

  Dr Monro: Yes it has been used for peanut allergy but it is not commonly used and there have been only two reports of sublingual immunotherapy causing any major effect, and that was when it was done in a rush desensitisation for peanut allergy.

  Q573  Lord Colwyn: This is a question for Dr Downing. In your evidence you said that allergic patients tend to be deficient in several of the vitamins and minerals necessary for optimum function of the immune system; correcting such deficiencies seems to improve their general health and lessen their hyper-reactivity." I would agree with that statement, namely that possibly zinc and vitamin C are some of the major offenders. Can you give us an answer on what is the evidence for this statement—and you are going to have to do it in about 60 seconds!

  Dr Downing: It is a good job that I prepared a written response which gives a number of things. The short answer is, yes, there is quite a bit of evidence but that environmental allergies, as we are now calling them, are no different from the rest of allergy in that respect, it is true of all asthmatics and allergics.[7]

  Lord Colwyn: Are you aware of any control trials that have been undertaken which have been published and peer-reviewed?

  Dr Downing: On treatment?

  Q574  Lord Colwyn: Yes.

  Dr Downing: Somewhat more limited.

  Q575  Lord Colwyn: To support your claim about vitamins and minerals?

  Dr Downing: You are talking about an intervention trial if you say a control trial. There have been studies that have shown—and I have a number here—that allergics in general are short on a variety of nutrients of which you are quite right zinc leads the league with vitamin C and the B vitamins and so forth.

  Lord Colwyn: My apologies for having to cut it so short.

  Q576  Lord Rea: Again asking a question that could occupy an hour, is there a possibility that some allergy treatments simply have a placebo effect rather than decreasing their true allergic response?

  Mr Harrison: Yes, I think so. I do not think that is anything new. I think that we must marshal all the aspects of treatment, both physical and psychological, in the treatment of a patient as a whole because, as I said, the allergy problem is a very complex problem and many, many patients come to us having run the gamut of the NHS, regretfully unsuccessfully, because all aspects of their problem are not addressed. Lifestyle must be looked at; the comfort of the patient must be looked at; the psychology of relationships must be looked at; and anything that reduces the stress. The allergy picture on test reduces as the stress level reduces, so if we can get the patient to reduce their stress level, if we can give them a belief in a positive outcome, then that reinforces the physical aspects of the treatment, so we must bring all these things together.

  Professor Wessely: Yes, obviously the placebo effect occurs across medicine and all of us would be a lot poorer if it did not. There is also the nocebic effect as well, I am afraid, which is where the placebo effect makes you worse. For example false allergy testing can make you worse by reinforcing the belief that you have an illness that in fact you do not and that there is a relationship between things when there is not, and by drawing attention away from the real cause of illnesses, so it is not just a straight situation. There is also a lot of literature on the nocebic effects of some interventions and tests, all of it highly relevant to this subject.

  Q577  Lord Haskel: You have told us about the regulation of practitioners. What about the clinics and the allergy treatments which are provided; are these adequately regulated and what could the Government do to protect the public from ineffective allergy treatments offered in these clinics?

  Mr Harrison: I can only speak about the treatments that our members offer. The remedies that they receive are made in a homeopathic way. They are remedies which have been tried and tested and produced for our members, something like 20,000 remedies a year, and these are going to patients who are either self-referred or referred by friends or, more importantly, referred by GPs. As far as the Government is concerned, it is already regulating the preparation of homeopathic medicines. The distribution of them should not be open to the normal aspects of commerce because, for instance, putting allergy neutralisation remedies on the shop shelf would be entirely irresponsible—no doubt very attractive as a money-making proposition but totally irresponsible—because people would just go and help themselves, dip into them, take this or that and waste their time and money. How the Government would regulate homoeopathically prepared medicines further, I am afraid that is beyond me, I do not think they could manage it.

  Dr Downing: If you are talking about doctors running clinics of this sort, then it is hard to see how we could be more regulated, quite honestly.

  Q578  Lord Haskel: It is the clinics and the treatment clinics which they provide that we are concerned about.

  Dr Downing: Yes, a clinic run by a doctor of that sort would come under the terms of the Health Care Commission and therefore also the National Minimum Standards. A number of us have either gone through the process or are going through the process at present, and I am myself, and I have to say that it has been challenging but I think it has been valuable and enabled us to improve what we do and the service that we provide.

  Q579  Lord Broers: But are you required to do that?

  Dr Downing: Yes.


7   Please see supplementary evidence. Back


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2007